shaping future business - euroforum · 23.10.2014 · huge gap in what we actually achieve in...

www.pharma-summit.com

Kindly supported by

Shaping future business

3rd international summit

22 and 23 October 2014, nhow Berlin

Prof. Dr

Christoph Meinel

Hasso Plattner Institute

Alexander Würfel

AbbVie Germany

Harry Strasser

Wearable Technologies AG

Dr Jan Schluechter

Novartis Pharma

Joel Dudley

Mount Sinai’s Icahn School of Medicine

...and other industry experts

Be inspired by...

2 days full of future insights and inspiration

Powerful speeches and panel discussions

10+ hours of networking

Disruption in Healthcare Vol. I-III

15 + international speakers


The recent ‘marriage’ of Big Data and Big Pharma –

the groundbreaking deal between google and

Novartis – illustrates once again: Healthcare is

fundamentally changing. New players are entering

the market. At the same time established stakeholders are

willing to rethink their business in order to keep a slice of the cake.

Current surveys prove: Many industry experts expect that pharma’s biggest competition

will be from companies other than the current competitors. But which is the best way to

shape future business? Compete or collaborate? How to implement current developments

like data mining and wearable technologies into the model?

Our annual forum will exclusively bring together decision makers, thought leaders and innovation experts willing to reshape the future of healthcare. Our Trend-setting topics include:

• Joint Value Creation as the only viable model in the future

• What patients want in 2035 – and how they are going to get it

• Why real innovation beyond the R&D realm must happen

• Friend or foe? Compete or collaborate? The new entrants in healthcare

• Bigger Data, better healthcare? New roads and opportunities

Are you ready to embrace innovation? Experience the inspiring atmosphere on your own

and become part of our open-minded think tank of industry experts.

Your healthy dose of innovation!

• Business Development

• Innovation and Strategy

• Strategic Alliances and Collaborations

• R + D

• Product and Brand Management

• Key Account Management

Meet decision makers, thought-leaders, innovation experts and entrepreneurs of the pharmaceutical and healthcare industry.

The summit will exclusively bring together dedicated people engaged in:

We are looking forward to welcoming you in Berlin.

Very good.I. Elfering, GlaxoSmithKline

Stimulating and engaging. You leave with a lot of actionable insights.M. Sundararajan, Shire

Inspiring eye-opener.A. Pollner, Bayer HealthCare

Great insights across a spectrum of innovation stakeholders. Now let’s convert them into ideas that deliver a positive impact for patients.C. Skelton, AbbVie

Challenging and thought-provoking.C. DeLoach, Vifor Fresenius Medical Care Renal Pharma Ltd

A great think tank.U. Diegel, iHealthLabs Europe


DAY ONE WEDNESDAY 22 OCTOBER 2014

8.30 Registration and Networking Breakfast

9.00 Welcome by EUROFORUM and The Chair of Day One

9.10 Disruption Times: The 10 biggest innovations in Healthcare

Jorge Juan Fernández García, Director of e-Health and Health

2.0, Hospital Sant Joan de Déu

9.40 Joint Value Creation – the only viable model in the future • What does joint value creation mean?

• What are the success levers and how do I know I am fi t for purpose?

• What are the real-life learnings and what is the outlook until 2020?

Dr Jan Schluechter, Global Head of KAM and Customer Model

Innovation, Novartis

10.00 Smarter Healthcare – where we might see it happen and why it’s taking so long

• Why Healthcare needs to get smarter

• What are the building blocks....and the hurdles on the way to

smarter Healthcare?

• There is light at the end of the tunnel – examples of current

approaches to Smart Healthcare

Chris Isler, former Global Head of Solution & Product

Development, Pfi zer Integrated Healthcare

10.20 All hands on deck – navigating the payers’ landscape • What do payers really want? The devil in the details.

• We are all payers now. Financing innovation.

• Population health vs. unit of One.

• If data is the currency of the new ecosystem, trust is the

central bank.

Patrick Flochel, Global Pharmaceutical Leader, EY

10.40 Panel Discussion Dr Jan Schlüchter, Patrick Flochel, Chris Isler

11.40 Health Economy becomes Digital Economy: product and strategy update for healthcare stakeholders in a nutshell

With doctors and patients being already digital habitats of our

digital society, the healthcare industry seems to react rather

to act. The gap between the potential of digital products and

business models and its todays implementation is symptomatic

as appellative. This complementary speaker tandem guides the

audience from implementations for internal “digital compatible”

corporate structures and processes up to external product and

strategy approaches.

Prof. Dr Mike Friedrichsen, President, The Humboldt School Of Digital Business

Dr Alexander Schachinger, CEO, EPatient RSD – the company for

epatient research, strategy, development

12.00 The Rise of the Social Health Operating System

Jorge Armanet, CEO and Co-Founder, HealthUnlocked

12.20 Real-world effective: designing human-centered services for what happens in real life

Thomas Sutton, Executive Creative Director, frog

12.40 Panel Discussion Prof. Dr Mike Friedrichsen, Jorge Armanet, Thomas Sutton

13.00 Networking Lunch

“It is time for a new approach and thinking in the industry. Everybody talks about a change of the commercial model in Healthcare. Nevertheless still the old push model prevails, where stakeholder work in their silos, however with diminishing returns.”

“There is lot’s of talking about Health 2.0, Connected Health, Remote Care, Personalised Medicine ... what Healthcare really needs are ways to become smarter. Smart = adjective \�smärt\: very good at learning or thinking about things.”

Dr Michael C. Müller, Managing Partner,

Cepton Stratgies/CRA

11.00 Disruption in Healthcare – Vol. I: Open Your Mind!

What patients want in 2035 – and how they are going to get it!

Interactive Warm-up-Session and Coffee Break

Prof. Andreas Mack, Dept. Leadership in Digital

Communication, The Berlin University of Arts and

Managing Partner, Partake

“Payers have a P&L responsibility for ensuring that sick people get access to treatment. We need a balance sheet approach to health”.

“In a digital society all businesses have a digital genome.”

“People (and yes, consumers) at the centre of the knowledge storage and the healthcare communications fl ows is the greatest revolution in the health industry ever and we are yet awaiting for the raise of the Social Health Operating System that can connect the dots and accelerate it all.”

“Even when medical science has provided us with the technology and knowledge needed to prevent or cure illness, there remains a huge gap in what we actually achieve in healthcare outcomes.”

“The only reason why we are interested in technologies is because they can help us solve the healthcare conundrum. Or can you think of any better ways of providing better care, at a lower cost, and more accessible?”

14.00 Disruption in Healthcare – Vol. II: Get Envolved!

Interactive Collaboration Session

How disruptive business models will empower patients and

revolutionize healthcare industries


DAY ONE CONTINUED

15.00 Coffee Break

15.30 Breaking up the Value Chain • Why does pharma unlock established structures in R&D and

operations

• Innovation driven by cooperations

• Partnering in R&D

• New kids on the block

• How to embed new business partners

Dr Michael C. Müller, Managing Partner, Cepton Strategies/CRA

15.55 Pushing the boundaries of science Marcus Schindler, VP, Head of Cardiovascular and Metabolic

Disease Innovative Medicines, AstraZeneca

16.20 Chronically Rethinking – what impulses will the pharmaceutical industry require in order to produce real innovation?

• Why real innovation beyond the R&D realm is a necessity for

biopharmaceutical companies

• Why real innovation is not a one-way-street but takes a different

time, space and drive – entrepreneurial thinking for established

structures

• Why real innovation needs a “design thinking approach”

Alexander Würfel, General Manager, AbbVie Germany

16.45 Packs, Drugs & Rock ‘n’ Roll! Abba and Antibodies, Aerosmith and Aspirin. An inspiring Medley of Change in fi ve Acts.

Tobias D. Gantner, MD, MBA, LL.M., CEO, HealthCare Futurists GmbH

Aleksandar Stojanovic, Founding Partner, Neon Bridges Consortium,

HealthCare Futurist

17.10 The ‘Google-ization’ of healthcare Dr Stephan Sigrist, Head of the W.I.R.E. (Web for

Interdisciplinary Research & Expertise)

17.30 Panel Discussion Friend or foe? Compete or collaborate? Who will be the

industry’s next amazon? Tobias Gantner, Marcus Schindler, Dr Stephan Sigrist,

Alexander Würfel

18.00 The Chair’s Takeaways Dr Michael C. Müller

“To deliver real patient-centric innovation, it takes more than a traditional innovation approach: facing today’s challenges in the economy and society (such as the demographic change) we need to reconsider our ways of thinking and working.”

19.00 Berlin at night

Let your hair down after a busy day. We invite you to enjoy dinner

and drinks in a relaxed atmosphere.

“Big money. Big players. Big aspirations. Both Rockstars and Blockbusters are all about turning IP into value. Yet today, the Major Record Labels are all gone - blown away by Digital Transformation. Now, Big Pharma moves along the same destructive path of downfall - stuck between denial and a deep wish for people-centricity. What has to change in order to keep the music playing nice and loud?”

15.20 Disruption in Healthcare – Vol. III: Get the results!


DAY TWO THURSDAY 23 OCTOBER 2014

8.00 Networking Breakfast

9.00 Welcome by EUROFORUM and The Chair of Day Two

9.15 Big Data – promise or threat? Prof. Dr Christoph Meinel, Head and Executive Director,

Hasso Plattner Institute

9.40 Wearable Technologies transforming the healthcare industries

So far the internet of things hasn’t made much headway into

patient care in the medical setting, but consumers are buying

wellness devices for a variety of reasons. Will the medical world

embrace that data?

• Overview and trends of wearable technologies

• Innovations in healthcare, fi tness and wellness markets

• Opportunities and challenges

Harry Strasser, Managing Partner, Wearable Technologies AG

10.05 In the hospital of the future data is one of your doctors Joel Dudley, PhD, Director of Biomedical Informatics, Assistant

Professor of Genetics and Genomic Sciences, Institute for

Genomics and Multiscale Biology, Icahn School of Medicine, Mount Sinai Hospital

10.30 Disrupting patient stratifi cation and diagnostics with Pattern Discovery & Machine Learning –

What we can learn from nature • The convergence of IT and biomedicine now enables molecular

maps of health/disease

• Pattern discovery & machine learning allow new approaches to

stratify customers/patients

• The challenges, however, range from a lack of standards for

data harvesting to the general reluctance to explore enchanted

ground; i.e. “risk” avoidance

Dr. Thomas Wilckens, CEO/CSO, InnVentis

11.00 Coffee and Networking Break

11.30 Panel Discussion Bigger Data, better Healthcare? New roads and opportunities Alexandre Capet, Chief Strategy, Voluntis Joel Dudley Drazen Nikolic, Partner, EY Harry Strasser Dr Thomas Wilckens

12.15 Open Innovation on prescription – Crowdsourcing in Healthcare

• Connecting patients, relatives, medical experts and interested

persons

• Active knowledge-transfer

• Provision of additional & new information

• Best practices in Health Care

Prof. Dr Johann Füller, Chair for Innovation and Entrepreneurship,

University of Innsbruck and CEO, HYVE AG

13.45 The Chair’s Takeaways Gerd W. Stuerz

14.00 Networking Lunch

14.30 Close of the summit

“Big Data are the “el Dorado” of the future particularly in the fi elds of pharma and healthcare. It provides the possibility to perform clinical studies with large number of participants and to computationally analyze any kind of huge health data sets from clinics or insurance companies. Investigating such large data sets makes it possible to identify how various things stick together. The highly complex medical and pharmaceutical industry can medically benefi t the most by the extensive correlations of their new on Big Data-based technologies.”

“In future patients will not go anymore to their doctor when feeling sick, but expect to be called when showing signs of illness.”

“The future is bright, but traditional players will soon face fi erce competition from the early adopters of Big DATA and the emerging PRECISION MEDICINE paradigm like Google with CALICO, NanthHealth, Human Longevity just to name the fi nancially best backed players.”

12.45 Energizing Health

It’s Pecha Kucha Time! Meet young entrepreneurs ready to revolutionize the healthcare

market: 20 slides, 20 seconds time per slide = 6.40 to surprise

and impress you with their innovative ideas

Gerd W. Stuerz, Managing Partner Life

Sciences, Healthcare and Chemicals,

Germany, Switzerland and Austria, EY

Located directly on the banks of the river Spree the nhow stands for a new

generation of hotels: offbeat, lively, dynamic. Get inspired by the Berlin kind

of way.

Your venue

“Rethinking Healthcare means to see Big Data, Technology-, Digitaland Open Innovation as a source of success for all stakeholders – from pharmaceutical and medical device companies, doctors, care givers, hospitals, to patients (and their relatives)”


GET TO THE HEART OF THE MATTER WITH:

Jorge Armanet

HealthUnlockedJoel Dudley PhD

Mount Sinai HospitalPatrick Flochel

EY

Prof. Dr Mike Friedrichsen

The Humboldt School of Digital Management

Prof. Dr Johann Füller

HYVE AGChris Isler

Pfi zer Integrated Healthcare

Jorge Juan Fernández Garcia

Hospital San Joan de DéuTobias D. Gantner

HealthCare FuturistsProf. Andreas Mack

Partake

Aleksander Stojanovic

Neon Bridges Consortium

Dr Stephan Sigrist

The W.I.R.E.Dr Alexander Schachinger

EPatient RSD

Harry Strasser

Wearable Technologies AG

Thomas Sutton

frogGerd W. Stuerz

EY

Alexander Würfel

AbbVie GermanyDr Michael C. Müller

Cepton Strategies/CRADr Jan Schlüchter

Novartis Pharma

Dr Thomas Wilckens

InnVentis


CONFERENCE PARTNER

About EY’s Global Life Sciences Center

Life sciences companies are facing challenging but promising times, as business

models evolve, stakeholder expectations increase, new markets emerge,

demographics shift, new technologies fl ourish, populations age and health care

expenditures rise. EY‘s Global Life Sciences Center brings together a worldwide team

of professionals to help you achieve your potential— a team with deep technical

experience in providing assurance, tax, transaction and advisory services. The

Center works to anticipate market trends, identify the implications and develop

points of view on relevant industry issues. It’s how EY makes a difference. For more

information, please visit www.ey.com/lifesciences or email global.lifesciences@

ey.com.

EY Maagplatz 1, 8010 Zürich, Switzerland

www.ey.com

PARTNER

AbbVie is a global, research-based biopharmaceutical company which combines

the focus and passion of a leading-edge biotech with the expertise and structure

of a long-established pharmaceutical leader. The company’s mission is to use its

expertise, dedicated people and unique approach to innovation to develop and

market advanced therapies that address some of the world’s most complex and

serious diseases.

AbbVie Deutschland GmbH & Co. KG Mainzer Straße 81, 65189 Wiesbaden

www.abbvie.de

COMPANY PRESENCE

The German capital region is one of the leading life sciences and healthcare

industry centers in the world. At the interface of business, science and clinics, the

HealthCapital cluster management drives networking and the technology transfer

and supports companies interested in relocating to the region. Berlin Partner for

Business and Technology and ZAB Brandenburg Economic Development Board are

responsible for managing the cluster.

Berlin Partner für Wirtschaft und Technologie GmbHHealthCapital Berlin-Brandenburg Fasanenstr. 85, 10623 Berlin

www.healthcapital.de

MEDIA PARTNERS

Make it your eventBecome partner of our summit!

We offer various packages of marketing and sponsoring opportunities

tailored to your personal needs. Let’s discuss your ideas!

+49(0)211/96 86-37 34

[email protected]

Annette Schwartze

Sponsoring & Exhibition

@events_health#rethinkhealth

Follow us on twitter Join our LinkedIn GroupRethinking Healthcare – Internatiional Summit

Questions? Please contact us: +49(0)211/9696-3599

Programme matters Friederike [email protected]

Organisation and customer enquiries Dana Knabbe [email protected]

Marketing and media partnerships Dörte [email protected]

registrationcodePersonal

EUROFORUM Deutschland SE, Postfach 11 12 34, 40512 Düsseldorf


Rethinking Healthcare

Are you ready to embrace innovation?22 and 23 October 2014, Berlin

Terms and conditions: http://www.euroforum.de/agben

More info and register

Online:

www.pharma-summit.com/

registration

Email:

[email protected]

Phone:

+49(0)211/9686-3599

Pricing

Standard rate at the price of

€ 1,999 p.p. plus VAT

Your Venue:

nhow Hotel Berlin

Stralauer Allee 3,

10245 Berlin

Germany

Phone:

+49(0)30/290299-0

For the latest updates including last year’s conference report, please visit: www.pharma-summit.com

shaping future business - euroforum · 23.10.2014 · huge gap in what we actually achieve in...

Documents